Evaluation on Inter-Assay Consistency and Inter-Reader Precision for PD-L1 Assays: Ventana SP263 and Dako 22C3 in Non-Small Cell Lung Cancer

被引：1

作者：

Lin, D. ^{[1
]}

Yang, X. ^{[1
]}

机构：

[1] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Pathol,Minist Educ, Beijing, Peoples R China

来源：

JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期

关键词：

PD-L1; Assays; TPS; Non-Small Cell Lung Cancer;

D O I：

10.1016/j.jtho.2019.08.1663

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.09-14

引用

页码：S774 / S774

页数：1

共 50 条

[21] Comparison of PD-L1 Expression Using 2 Validated PD-L1 IHC 22C3 pharmDx Methods in Non-Small Cell Lung Cancer in a Routine Hospital Setting [J].

Skov, Birgit G. .

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2021, 29 (01) :49-55

[22] The Clinicopathological and Molecular Associations of PD-L1 Expression in Non-small Cell Lung Cancer: Analysis of a Series of 10,005 Cases Tested with the 22C3 Assay [J].

Evans, Matthew ;

O'Sullivan, Brendan ;

Hughes, Frances ;

Mullis, Tina ;

Smith, Matthew ;

Trim, Nicola ;

Taniere, Philippe .

PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (01) :79-89

[23] Updated Analysis of Outcomes by Histology vs Cytology PD-L1 22C3 Antibody Testing in Advanced Non-Small Cell Lung Cancer [J].

Sathiyapalan, A. ;

Wang, Y. ;

Juergens, R. ;

Butcher, M. ;

Naqvi, A. ;

Cutz, J. .

JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) :S379-S380

[24] SP142 PD-L1 Scoring Shows High Interobserver and Intraobserver Agreement in Triple-negative Breast Carcinoma But Overall Low Percentage Agreement With Other PD-L1 Clones SP263 and 22C3 [J].

Pang, Jia-Min B. ;

Castles, Belinda ;

Byrne, David J. ;

Button, Peter ;

Hendry, Shona ;

Lakhani, Sunil R. ;

Sivasubramaniam, Vanathi ;

Cooper, Wendy A. ;

Armes, Jane ;

Millar, Ewan K. A. ;

Raymond, Wendy ;

Roberts-Thomson, Samuel ;

Kumar, Beena ;

Burr, Marian ;

Selinger, Christina ;

Harvey, Kate ;

Chan, Charles ;

Beith, Jane ;

Clouston, David ;

O'Toole, Sandra A. ;

Fox, Stephen B. .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2021, 45 (08) :1108-1117

[25] Evaluating programmed death-ligand 1 (PD-L1) in head and neck squamous cell carcinoma: concordance between the 22C3 PharmDx assay and the SP263 assay on whole sections from a multicentre study [J].

Cerbelli, Bruna ;

Girolami, Ilaria ;

Eccher, Albino ;

Costarelli, Leopoldo ;

Taccogna, Silvia ;

Scialpi, Renzo ;

Benevolo, Maria ;

Lucante, Teresa ;

Alo, Piero Luigi ;

Stella, Francesca ;

Pignataro, Maria Gemma ;

Fadda, Guido ;

Perrone, Giuseppe ;

D'Amati, Giulia ;

Martini, Maurizio .

HISTOPATHOLOGY, 2022, 80 (02) :397-406

[26] Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients [J].

Ilie, Marius ;

Ngo-Mai, Melanie ;

Long-Mira, Elodie ;

Lassalle, Sandra ;

Butori, Catherine ;

Bence, Coraline ;

Hamila, Marame ;

Hofman, Veronique ;

Hofman, Paul .

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2018, (139)

[27] Intra- and Inter-Observer Reproducibility Study of PD-L1 Biomarker in Non-Small Cell Lung Cancer (NSCLC) - The DREAM STUDY [J].

Cooper, Wendy ;

Russell, Prudence ;

Huot-Marchand, Phillipe ;

Cherian, Maya ;

Duhig, Edwina ;

Godbolt, David ;

Jessup, Peter ;

Khoo, Christine ;

Leslie, Connull ;

Mahar, Annabelle ;

Moffat, David ;

Sivasubramaniam, Vanathi ;

Grattan, Amanda ;

Reznichenko, Alena ;

Woodgate, Ann-Marie ;

Fox, Sephen .

JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) :S814-S815

[28] PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability [J].

Munari, Enrico ;

Zamboni, Giuseppe ;

Marconi, Marcella ;

Sommaggio, Marco ;

Brunelli, Matteo ;

Martignoni, Guido ;

Netto, George J. ;

Moretta, Francesca ;

Mingari, Maria Cristina ;

Salgarello, Matteo ;

Terzi, Alberto ;

Picece, Vincenzo ;

Pomari, Carlo ;

Lunardi, Gianluigi ;

Cavazza, Alberto ;

Rossi, Giulio ;

Moretta, Lorenzo ;

Bogina, Giuseppe .

ONCOTARGET, 2017, 8 (52) :90123-90131

[29] Programmed cell death ligand-1 (PD-L1) expression in extrahepatic biliary tract cancers: a comparative study using 22C3, SP263 and E1L3N anti-PD-L1 antibodies [J].

Ahn, Soomin ;

Lee, Yangkyu ;

Kim, Ji-Won ;

Lee, Jong-Chan ;

Hwang, Jin-Hyeok ;

Yoon, Yoo-Seok ;

Cho, Jai Young ;

Han, Ho-Seong ;

Choi, YoungRok ;

Kim, Haeryoung .

HISTOPATHOLOGY, 2019, 75 (04) :526-536

[30] Mitomycin C synergizes with PD-L1 blockade in treatment of non-small cell lung cancer [J].

LUO Min ;

ZHANG Hong ;

WU Shao-cong ;

CHEN Zhen ;

LIANG Shao-bo ;

WANG Fang ;

FU Li-wu .

中国药理学与毒理学杂志, 2019, (10) :885-885

← 1 2 3 4 5 →